Furthermore, leptin is an established regulator of body weight, and leptin/adiponectin dysregulation has been associated with cardiovascular disease, metabolic syndrome, and nonalcoholic fatty liver disease (DiNicolantonio, Lucan, & O'Keefe, 2016). This evidence concerns the gene LEP and metabolic dysfunction-associated steatotic liver disease.